Fosrenol
NDC 54092-253, lanthanum carbonate, tablet, chewable, from Takeda Pharmaceuticals America, Inc..
- Product NDC
- 54092-253
- Status
- Listed
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Dosage form
- TABLET, CHEWABLE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021468
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/54092-253 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LANTHANUM CARBONATE750 mg/1
Pharmacologic classes
Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 54092-253-90 | 54092025390 | 6 BOTTLE in 1 PACKAGE (54092-253-90) / 15 TABLET, CHEWABLE in 1 BOTTLE (54092-253-15) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/f10776b2-2c25-4343-aabe-68f302e5cb54
Use it
Look up 54092-253 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/54092-253 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 54092-253. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.